Company
Every investor coverage indicates participated in a round Nestle Health Science raised.
Companies Nestle Health Science acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Nestle Health Science. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Melbourne biotech Aravax, developer of the peanut allergy immunotherapy PVX108, adds former ALK-Abello chief Carsten Hellmann and ex-Aimmune commercial head Andrew Oxtoby to its board ahead of Phase 3.
Weekly agrifoodtech roundup: Zepto and Getir raise big rounds, an Australian recycled-plastics startup lands $100 million backed by Lululemon, SoundHound acquires Allset, and several agrifood companies announce executive appointments.